MEROPENEM ANHYDROUS
Substance profile for UNII YOP6PX0BAO, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 441130Substance Identity#
- UNII
- YOP6PX0BAO
- Preferred term
- MEROPENEM ANHYDROUS
- Registry number
- 96036-03-2
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C17H25N3O5S
Structure render from PubChem CID 441130Chemical And Database Identifiers#
- InChIKey
- DMJNNHOOLUXYBV-PQTSNVLCSA-N
- SMILES
- C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)=C(N2C1=O)C(O)=O
- RxCUI
- 1546029
- PubChem
- 441130
- NCIt
- C61833
- INN ID
- 6396
DailyMed Socrata Ingredients#
DailyMed label, SPL version table| DailyMed label | SPL version |
|---|
| These highlights do not include all the information needed to use Meropenem for Injection safely and effectively. See full prescribing information for Meropenem for Injection. Meropenem for Injection Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection and other antibacterial drugs, Meropenem for Injection should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible b | 17 |
| MERREM IV (MEROPENEM) INJECTION [ASTRAZENECA PHARMACEUTICALS LP] | 14 |
| MEROPENEM AND SODIUM CHLORIDE INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 9 |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 9 |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 8 |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 5 |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 2 |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 |